Fran Adar Joins Spectroscopy's Editorial Advisory Board
Spectroscopy is pleased to announce the addition of Fran Adar to its editorial advisory board.
Adar was a post-doctoral Fellow and Assistant Professor at the Johnson Foundation, Department of Biophysics, University
of Pennsylvania (Philadelphia, Pennsylvania) from 1972 to 1978. She has been a Raman applications scientist, manager, and
principal scientist at Jobin Yvon/Horiba Scientific (Edison, New Jersey) since 1978.
Drawing on her background in education and experience in physics and biophysics, Adar has developed applications for the
Raman microscope. These application areas include semiconductors, ceramics, containment identification, polymer morphology,
catalysts, metal oxides, and pharmaceuticals.
Adar has received awards from the local Microbeam Society (Irene Dion Payne), the Federation of Analytical Chemistry and
Spectroscopy Societies (Charles Mann Award), the Coblentz Society (William-Wright Award), and has delivered an address at
the prestigious Waters Symposium at the Pittsburgh Conference on the history of the development of Raman instrumentation.
In 2012, Adar was invited to be a fellow of the Society for Applied Spectroscopy (Frederick, Maryland). She continues to work
with new and experienced Raman users developing applications and pushing instrumentation developments to accommodate new applications
enabled by evolving techniques.
Adar has been writing the "Molecular Spectroscopy Workbench" column for Spectroscopy since 2007. She now coauthors that column with her colleague David Tuschel.
Rigaku and Emerald Bio Create Strategic Alliance
Rigaku (The Woodlands, Texas) has acquired the crystallization reagent and consumables business, including crystallization
screening kits, from Emerald Bio (Bainbridge Island, Washington). The companies have agreed to work together to develop new
products and solutions for the field of protein science.
"The addition of these consumables and screening kits is another step in creating a single contact point for our instrumentation
customers, improving the efficiency of their workflow," said Catherine Klein, president of Rigaku Americas Corporation's Life
Sciences Division. "Further, having Emerald Bio as a development partner and customer will help ensure that we are at the
forefront of new product needs in protein science."
"Having Rigaku, the world leading protein crystallography instrumentation company, as a development partner is ideal for
Emerald," said Johan Pontin, CEO of Emerald Bio.